SciELO - Scientific Electronic Library Online

 
vol.34 suppl.2Compliance in schizophreniaPhysiopathology of schizophrenia: current aspects author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

Share


Archives of Clinical Psychiatry (São Paulo)

Print version ISSN 0101-6083On-line version ISSN 1806-938X

Abstract

ELKIS, Hélio  and  LOUZA, Mário Rodrigues. New antipsychotics for the treatment of schizophrenia. Rev. psiquiatr. clín. [online]. 2007, vol.34, suppl.2, pp.193-197. ISSN 1806-938X.  http://dx.doi.org/10.1590/S0101-60832007000800009.

BACKGROUND: The second generation antipsychotics represent the great achievement in the treatment of schizophrenia of the last decades. However in the last years some new antipsychotics were synthesized and such new compounds may represent great perspectives for the field of the treatment of schizophrenia. Some of these compounds are in use while others are still on evaluation through clinical trials. OBJECTIVE: Summarize the current knowledge of new antipsychotics. METHODS: PubMed search as well literature provided by the manufactures. RESULTS AND CONCLUSIONS: We present the main pharmacological characteristics as well as profiles of efficacy, security and tolerability of the following compounds: Asenapine, ACP-103, Bifeprunox, Paliperidone, Long Acting Injectable Risperidone and Sertindole.

Keywords : Antipsychotics; neuroleptics; asenapine; ACP-103; bifeprunox; paliperidone; long acting injectable risperidone; sertindole.

        · abstract in Portuguese     · text in Portuguese     · Portuguese ( pdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License